Inventor · disambiguated record
John E. Shively
Also filed as: SHIVELY JOHN E · SHIVELY JOHN ERNEST
27 granted patents·9 pending applications·229 citations·filing 1985–2024
96Inventor score
Files withHOPE CITY28WU ANNA M2BECKMAN RESEARCH INST OF CITY1LOS ALAMOS NAT SECURITY LLC1SWANSON BASIL I1
Top patents by PatentIndex Score
36 records- 0193US7776330B2Humanized anti-CEA T84.66 antibody and uses thereofHOPE CITY·Filed 2007·Granted Aug 17, 2010·25 cites·9 claims
- 0288US10967070B2Cell penetrating conjugates and methods of use thereofHOPE CITY·Filed 2016·Granted Apr 6, 2021·3 cites·8 claims
- 0387US7273608B2Humanized anti-CEA T84.66 antibody and uses thereofHOPE CITY·Filed 2005·Granted Sep 25, 2007·10 cites·6 claims
- 0481US9701754B1Covalent disulfide-linked diabodies and uses thereofWU ANNA M·Filed 2010·Granted Jul 11, 2017·2 cites·2 claims
- 0579US9765155B2Covalent disulfide-linked diabodies and uses thereofWU ANNA M·Filed 2012·Granted Sep 19, 2017·2 cites·1 claims
- 0679US5081235AChimeric anti-cea antibodyHOPE CITY·Filed 1989·Granted Jan 14, 1992·40 cites·2 claims
- 0773US10603328B2Methods of treating advanced prostate cancerHOPE CITY·Filed 2018·Granted Mar 31, 2020·1 cites·35 claims
- 0869US4873313ASpecific hybridoma cell line and monocolonal antibodies produced from such specific hybridoma cell line and method of using such monoclonal antibodies to detect carcinoembryonic antigensBECKMAN RESEARCH INST OF CITY·Filed 1985·Granted Oct 10, 1989·37 cites·6 claims
- 0967US5075431AChimeric anti-CEA antibodyHOPE CITY·Filed 1990·Granted Dec 24, 1991·25 cites·11 claims
- 1066US5137695AApparatus for the sequential performance of chemical processesHOPE CITY·Filed 1990·Granted Aug 11, 1992·21 cites·2 claims
- 1164US7541196B2Planar optical waveguide based sandwich assay sensors and processes for the detection of biological targets including early detection of cancersLOS ALAMOS NAT SECURITY LLC·Filed 2005·Granted Jun 2, 2009·1 cites·25 claims
- 1264US2025074982A1Bispecific antibodies and uses thereofHOPE CITY·Filed 2024·Application pending·0 cites
- 1362US5861125AProtein or peptide sequencing method and apparatusHOPE CITY·Filed 1990·Granted Jan 19, 1999·12 cites·9 claims
- 1462US2018155449A1Covalent disulfide-linked diabodies and uses thereofHOPE CITY·Filed 2017·Application pending·0 cites
- 1560US11541062B2Methods of treating advanced prostate cancerHOPE CITY·Filed 2020·Granted Jan 3, 2023·0 cites·16 claims
- 1656US12043673B2Complementary RNA linked bispecific T-cell engaging antibodiesHOPE CITY·Filed 2021·Granted Jul 23, 2024·0 cites·12 claims
- 1756US2023256122A1Combination therapy for treating cancerHOPE CITY·Filed 2022·Application pending·0 cites
- 1854US9005969B2Generation of novel bone forming cells (monoosteophils) from LL-37 treated monocytesHOPE CITY·Filed 2013·Granted Apr 14, 2015·0 cites·20 claims
- 1954US2023190799A1Chimeric antigen receptor t cells targeting cea and anti-cea-il2 immunocytokines for cancer therapyHOPE CITY·Filed 2022·Application pending·0 cites
- 2053US2023001027A1Metal chelating agents and methods of using the sameHOPE CITY·Filed 2020·Application pending·0 cites
- 2151US5061635AProtein or peptide sequencing methodHOPE CITY·Filed 1988·Granted Oct 29, 1991·6 cites·3 claims
- 2251US2011217459A1Process for conjugating biomolecules to hydrophobic membrane-incorporated moleculesSWANSON BASIL I·Filed 2007·Application pending·0 cites
- 2350US5180807AC-terminal peptide or protein sequencing reagent and methodHOPE CITY·Filed 1991·Granted Jan 19, 1993·14 cites·14 claims
- 2448US5432092AC-terminal peptide sequencing using diphenyl phosphoroisothiocyanatidate and pyridineHOPE CITY·Filed 1992·Granted Jul 11, 1995·13 cites·5 claims
- 2548US2004171175A1Process for conjugating biomolecules to hydrophobic membrane-incorporated moleculesFiled 2003·Application pending·0 cites
- 2646US2022280568A1Dual bispecific antibody compounds and uses thereofHOPE CITY·Filed 2020·Application pending·0 cites
- 2744US8513013B2Generation of novel bone forming cells (monoosteophils) from LL-37 treated monocytesZHANG ZHIFANG·Filed 2011·Granted Aug 20, 2013·0 cites·9 claims
- 2841US5227309AC-terminal peptide sequencing methodHOPE CITY·Filed 1991·Granted Jul 13, 1993·5 cites·9 claims
- 2941US2020181264A1Bispecific antigen-binding moleculeHOPE CITY·Filed 2018·Application pending·0 cites
- 3039US5432091AN-terminal sequencing of proteins and peptidesHOPE CITY·Filed 1993·Granted Jul 11, 1995·4 cites·4 claims
- 3137US5986071AMethod for C-terminal degradation of peptides and proteinsHOPE CITY·Filed 1997·Granted Nov 16, 1999·1 cites·23 claims
- 3237US5432093ASequential degradation of proteins and peptides from the N-terminusHOPE CITY·Filed 1992·Granted Jul 11, 1995·6 cites·5 claims
- 3336US10471161B2Vinylsulfone-based 18F-labeling compositions and methods and uses thereofUNIV OF SOUTHERN CALIFORNIA USC STEVENS·Filed 2014·Granted Nov 12, 2019·0 cites·6 claims
- 3430US5541114ASequencing of protein immobilized on polytetrafluoroethylene supportsHOPE CITY·Filed 1992·Granted Jul 30, 1996·1 cites·5 claims
- 3529US5998213AC-terminal sequencing of peptides which may include prolineHOPE CITY·Filed 1994·Granted Dec 7, 1999·0 cites·6 claims
- 3629US5525707AN-terminal peptide degradation utilizing dialkylthiocarbamoylhalidesHOPE CITY·Filed 1992·Granted Jun 11, 1996·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when John E. Shively files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →